Source:http://linkedlifedata.com/resource/pubmed/id/17654552
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-2
|
pubmed:abstractText |
Dimeric dihydrodiol dehydrogenase (DD) catalyses the nicotinamide adenine dinucleotide phosphate (NADP+)-dependent oxidation of trans-dihydrodiols of aromatic hydrocarbons to their corresponding catechols. This is the first report of the crystal structure of the dimeric enzyme determined at 2.0 A resolution. The tertiary structure is formed by a classical dinucleotide binding fold comprising of two betaalphabetaalphabeta motifs at the N-terminus and an eight-stranded, predominantly antiparallel beta-sheet at the C-terminus. The active-site of DD, occupied either by a glycerol molecule or the inhibitor 4-hydroxyacetophenone, is located in the C-terminal domain of the protein and maintained by a number of residues including Lys97, Trp125, Phe154, Leu158, Val161, Asp176, Leu177, Tyr180, Trp254, Phe279, and Asp280. The dimer interface is stabilized by a large number of intermolecular contacts mediated by the beta-sheet of each monomer, which includes an intricate hydrogen bonding network maintained in principal by Arg148 and Arg202. Site-directed mutagenesis has demonstrated that the intact dimer is not essential for catalytic activity. The similarity between the quaternary structures of mammalian DD and glucose-fructose oxidoreductase isolated from the prokaryotic organism Zymomonas mobilis suggests that both enzymes are members of a unique family of oligomeric proteins and may share a common ancestral gene.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Molecular Probes,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/trans-1,2-dihydrobenzene-1,2-diol...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1097-0134
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2007 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
176-87
|
pubmed:meshHeading |
pubmed-meshheading:17654552-Animals,
pubmed-meshheading:17654552-Catalytic Domain,
pubmed-meshheading:17654552-Crystallography, X-Ray,
pubmed-meshheading:17654552-DNA, Complementary,
pubmed-meshheading:17654552-Dimerization,
pubmed-meshheading:17654552-Enzyme Inhibitors,
pubmed-meshheading:17654552-Humans,
pubmed-meshheading:17654552-Hydrogen Bonding,
pubmed-meshheading:17654552-Models, Molecular,
pubmed-meshheading:17654552-Molecular Probes,
pubmed-meshheading:17654552-Mutagenesis, Site-Directed,
pubmed-meshheading:17654552-Oxidoreductases,
pubmed-meshheading:17654552-Protein Structure, Secondary
|
pubmed:year |
2008
|
pubmed:articleTitle |
Structures of dimeric dihydrodiol dehydrogenase apoenzyme and inhibitor complex: probing the subunit interface with site-directed mutagenesis.
|
pubmed:affiliation |
Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|